Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous methotrexate plus glucocorticoid for pemphigus
ChiCTR-TRC-12003540Phase 4Completed
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pemphigus comparing Glucocorticoid group with Glucocorticoid plus methotrexate group (2 arms). Primary endpoints: Pemphigus Disease Area Index, Time to cessation of new blister formation and 3 more. Started Jan 2011; status: completed.
02
Drugs
methotrexateprednisone
03
Conditions
pemphigus
Beyond the preview
Go deeper on ChiCTR-TRC-12003540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003540.